Wardwizard Healthcare to Raise Rs 12.5 Crore via Preferential Issue

Issue Size: Rs 12.5 crore via 1.25 crore warrants; Authorized Capital: Increased to Rs 25 crore.

Reader Takeaway: Capital infusion supports expansion and promoter-group investments, though shareholder approval remains a key hurdle at the AGM.

What just happened

Wardwizard Healthcare has received board approval to raise up to Rs 12.5 crore through the issuance of 1.25 crore fully convertible warrants. These warrants are priced at Rs 10 each and can be converted into equity shares within 18 months of allotment. To accommodate this capital expansion, the company has also increased its authorized share capital from Rs 7.5 crore to Rs 25 crore.

Why this matters

The capital raised is earmarked for growth initiatives, including strategic investments in promoter-group entities like Wardwizard Medicare Private Limited, as well as general working capital needs. The increase in authorized capital provides the company with greater flexibility for future equity fundraising or corporate restructuring activities.

Governance and Board Updates

The company is strengthening its leadership team with the appointment of Ms. Sathi Kundu as an Additional Independent Director for a five-year term. Furthermore, Mr. Yuvraj Priyadarshi, who joined as an Additional Director in March 2026, has been designated as a Whole-time Director effective September 30, 2026, pending shareholder approval.

Annual General Meeting

Wardwizard Healthcare will host its 42nd Annual General Meeting on September 30, 2026. Shareholders will vote on the proposed warrant issuance, the increase in authorized capital, and the new director appointments. The company has scheduled a book closure period from September 23 to September 30, 2026, and will facilitate remote e-voting for investors.